KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 81 filers reported holding KEROS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,490,400 | -20.7% | 580,000 | 0.0% | 0.33% | -15.7% |
| Q2 2023 | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
| Q1 2023 | $12,810,000 | -29.4% | 300,000 | -29.8% | 0.24% | -3.7% |
| Q2 2021 | $18,152,000 | -31.0% | 427,414 | 0.0% | 0.24% | -37.4% |
| Q1 2021 | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
| Q4 2020 | $24,407,000 | – | 346,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |